Clinical trials
Primary Hyperparathyroidism clinical trials
Below are recruiting primary hyperparathyroidism clinical trials, each written for real people, not researchers. We’re tracking 14 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06562881Recruiting
Helping People Get Parathyroid Surgery When Needed
This study looks at whether a patient navigator (a person who helps guide you through the healthcare system) can help people who need surgery for primary hyperparathyroidism but may face barriers due to race, income, or insurance. It aims to make surgery more accessible and improve outcomes.
Philadelphia, PennsylvaniaAges 18 years+ - NCT05469087Recruiting
Study of primary hyperparathyroidism in adults
This study follows adults with primary hyperparathyroidism (a hormone-related condition that affects calcium levels). It aims to better understand the condition and who it affects, which may help improve care over time.
Nantes, Loire-AtlantiqueAges 18 years+ - NCT06230380Recruiting
Autofluorescence camera in parathyroid surgery
This trial tests whether a special camera (autofluorescence) can help surgeons find abnormal parathyroid glands during surgery for primary hyperparathyroidism. It involves exploratory surgery, not a focused approach, and may help improve surgical success.
AarhusAges 18 years+ - NCT06859580RecruitingPhase 4
Bisphosphonate before parathyroid surgery for bone health
This study tests whether giving a bisphosphonate (a bone-strengthening drug) before parathyroid surgery helps protect bone health in people with primary hyperparathyroidism. It's for those who already have thin bones and are planning surgery.
Aarhus N, Central Region of DenmarkAges 50 years+ - NCT07138820Recruiting
Comparing scans to find parathyroid gland disease
This study compares a newer type of scan (18F-choline PET/CT) to standard imaging to help doctors locate overactive parathyroid glands. The goal is to see if the newer scan works better for planning surgery in people with primary hyperparathyroidism.
LundAges 18 years+ - NCT05997810Recruiting
Parathyroid tumor genetics study
This study looks at the genetic makeup of parathyroid tumors in people with hyperparathyroidism. It aims to understand why these tumors form and how they behave, which could help improve treatment decisions.
St Louis, MissouriAges 18–80 - NCT07444723RecruitingPhase 2/Phase 3
New imaging to find parathyroid tumors before surgery
This study tests two advanced imaging techniques (PET/MR and PET/CT) to find overactive parathyroid glands or tumors that need surgery. Participants get a special scan before surgery to help surgeons locate the problem more accurately.
Bethesda, MarylandAges 18–100 - NCT07744425Enrolling by invitation
Surgical imaging device study
This study tests a new camera that helps surgeons see tissues more clearly during surgery. It may help improve surgical precision and safety.
Palo Alto, CaliforniaAges 18–90 - NCT03039439Recruiting
Tissue study of parathyroid tumors to understand tumor biology
This study looks at blood and/or tissue samples from people with parathyroid problems to better understand different types of parathyroid tumors. It does not test a new medicine—instead, researchers analyze samples to learn what makes each tumor type different.
Houston, TexasAges Any age - NCT03935984RecruitingPhase 4
Calcitonin before scan to improve parathyroid detection
This study looks at whether taking calcitonin before a special parathyroid scan (SPECT-CT) makes the scan easier to read. It’s for people with primary hyperparathyroidism who want surgery, and may help doctors find the right gland more reliably.
Toledo, OhioAges 18 years+ - NCT04969926Recruiting
Study of parathyroid problems in children and adults
This is an observational study that follows people who have or may develop parathyroid-related conditions. The goal is to better understand how these problems change over time and what patterns show up, which can help improve future care.
Bethesda, MarylandAges 6 months–100 years - NCT06450431Recruiting
Parathyroid symptom assessment study
This study looks at how your parathyroid condition affects your symptoms and quality of life. You will fill out a simple questionnaire about your health.
Nantes, Loire-AtlantiqueAges 18 years+ - NCT06523582Recruiting
Genetic study of neuroendocrine tumors in Mexican patients
This study aims to find genetic causes of neuroendocrine tumors in Mexican patients. By understanding your DNA, researchers hope to improve diagnosis and treatment for people with these rare conditions.
Mexico City, Mexico CityAges 18 years+ - NCT07379463Recruiting
PET/CT imaging study for people with cancer
This study uses a special PET/CT scan to look at amino acid transporters in tumors. It may help doctors better understand and diagnose certain cancers.
Hefei, AnhuiAges 18–90
Hear when a new Primary Hyperparathyroidism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for primary hyperparathyroidism?
- Yes. Clin2 currently lists 14 recruiting primary hyperparathyroidism studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a primary hyperparathyroidism trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a primary hyperparathyroidism trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.